Misha Tavaf, DPM
Podiatry · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 27
- 8 carriers
- Office
- 1
Offices
1 location · Bay Area Foot Care Inc · 127 clinicians in this group
Hospitals listed: 059122 · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
27 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tavaf’s office at (408) 358-6234 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$107,640
Medicare paid this office $107,640 for 242 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 159 | $25,880 | $81 |
| Return visit (30+ min) | 67 | $10,634 | $118 |
| Removal of fingernails or toenails, 6 or more nails | 91 | $7,301 | $42 |
| Removal of noncancer thickened skin growth, 1 growth | 59 | $6,747 | $71 |
| New patient visit (45+ min) | 46 | $6,170 | $134 |
See all 12 services
| Short return visit (20+ min) | 159 | $25,880 | $81 |
| Return visit (30+ min) | 67 | $10,634 | $118 |
| Removal of fingernails or toenails, 6 or more nails | 91 | $7,301 | $42 |
| Removal of noncancer thickened skin growth, 1 growth | 59 | $6,747 | $71 |
| New patient visit (45+ min) | 46 | $6,170 | $134 |
| New patient visit (30+ min) | 43 | $3,769 | $88 |
| X-ray of foot, minimum of 3 views | 61 | $3,261 | $35 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 14 | $1,889 | $105 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 12 | $1,183 | $85 |
| Simple separation of fingernail or toenail from nail bed, first nail | 11 | $1,033 | $94 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $16 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 17 | $2 | None |
Procedures Medicare counted
| Removal of nail tissue | 357 | More than 80% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 192 | More than 91% of doctors who do this |
| Removal or shaving of skin growth | 263 | More than 92% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
242 Original Medicare patients in 2024. Average age 77 · Women 57% · Also on Medicaid 11% · Health risk score 1.46. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Coronary heart disease 32% · Diabetes 31% · Atrial fibrillation 23% · Depression 23% · Chronic kidney disease 21% · Heart failure 19% · Cancer 15% · COPD 10% · Dementia 10% · Stroke 9%.
The office billed $485,894, Medicare allowed $141,637 and paid $107,640; for 1,387 services of 78 kinds; $14,078 of it was for drugs given in the office and $93,562 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 242 | 1,387 | 77 | 1.46 | $485,894 | $107,640 |
| 2023 | 82 | 371 | 77 | 1.20 | $143,604 | $28,870 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 44 | $5,391 | $82 |
| New patient visit (45+ min) | 24 | $3,515 | $146 |
| Return visit (30+ min) | 16 | $2,691 | $122 |
| New patient visit (30+ min) | 20 | $2,139 | $107 |
| Removal of fingernails or toenails, 6 or more nails | 27 | $1,361 | $43 |
| X-ray of foot, minimum of 3 views | 24 | $1,099 | $37 |
Drugs they prescribed that Part D paid
$4,794
Pharmacies billed $4,794 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (12 of 92) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
90 generic and fewer than 11 brand-name prescriptions · $4,794 in drug cost · 21 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciclopirox | 11 | $324 | $29 |
| Cephalexin | 11 | $72 | $7 |
| Meloxicam | 19 | $43 | $2 |
Year by year
| 2024 | 92 | 55 | 13% (12) | None | $4,794 |
| 2023 | 27 | 20 | None | None | $837 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$3,363 in 2025
| 2025 | 21 | 55 | None | $3,363 |
| 2024 | 14 | 28 | None | $1,908 |
| 2023 | 5 | 7 | None | $288 |
| 2022 | 2 | 3 | None | $1,343 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medical Device Business Services | Motoband | $1,401 | 6 payments
|
| DePuy Synthes Sales | Motoband | $341 | 6 payments
|
| Smith+Nephew | Grafix | $286 | 7 payments
|
| Stryker | Ortholoc 2 Lapifuse | $271 | 8 payments
|
| Amgen | Krystexxa | $226 | 7 payments
|
| Avita Medical Americas | Recell | $135 | 1 payment
|
See all 55 published payments
| Smith+Nephew | Meals · 2025-12-09 | Collagenase Santyl | $9 |
| Organogenesis | Meals · 2025-12-03 | Puraply Wound Matrix | $121 |
| Vertex Pharmaceuticals | Meals · 2025-11-19 | Journavx | $23 |
| Stryker | Meals · 2025-11-06 | N/A | $19 |
| Smith+Nephew | Meals · 2025-10-31 | Grafix | $43 |
| DePuy Synthes Sales | Meals · 2025-10-29 | Motoband Cp | $29 |
| Orthofix Medical | Meals · 2025-10-18 | Physio-Stim | $23 |
| Orthofix Medical | Meals · 2025-10-11 | Physio-Stim | $26 |
| Amgen | Meals · 2025-10-02 | Krystexxa | $13 |
| Treace Medical Concepts | Meals · 2025-10-02 | Percuplasty Tray | $32 |
| Stryker | Meals · 2025-10-01 | Ortholoc 2 Lapifuse | $27 |
| Medical Device Business Services | Travel · 2025-09-27 | Motoband | $634 |
| Medical Device Business Services | Meals · 2025-09-27 | Motoband | $24 |
| Medical Device Business Services | Travel · 2025-09-27 | Motoband | $652 |
| Medical Device Business Services | Travel · 2025-09-27 | Motoband | $37 |
| Medical Device Business Services | Meals · 2025-09-27 | Motoband | $3 |
| Medical Device Business Services | Meals · 2025-09-27 | Motoband | $50 |
| DePuy Synthes Sales | Meals · 2025-09-27 | Minibunion | $112 |
| DePuy Synthes Sales | Meals · 2025-09-26 | Motoband | $22 |
| DePuy Synthes Sales | Meals · 2025-09-12 | Motoband | $36 |
| Stryker | Meals · 2025-09-12 | Ortholoc 2 Lapifuse | $140 |
| Stryker | Meals · 2025-09-09 | Ortholoc 2 Lapifuse | $21 |
| Paratek Pharmaceuticals | Meals · 2025-09-08 | Nuzyra | $25 |
| Amgen | Meals · 2025-09-04 | Krystexxa | $13 |
| Amgen | Meals · 2025-09-03 | Krystexxa | $27 |
| ANI Pharmaceuticals | Meals · 2025-08-20 | Purified Cortrophin Gel | $25 |
| Amgen | Meals · 2025-08-13 | Krystexxa | $9 |
| Averitas Pharma | Meals · 2025-08-13 | Qutenza | $21 |
| Pacira Pharmaceuticals | Meals · 2025-08-12 | Exparel | $31 |
| Paratek Pharmaceuticals | Meals · 2025-08-06 | Nuzyra | $20 |
| Paragon 28 | Meals · 2025-08-01 | Portfolio | $55 |
| Stryker | Meals · 2025-07-29 | Prostep Mica | $8 |
| Smith+Nephew | Meals · 2025-07-11 | Grafix | $15 |
| Paratek Pharmaceuticals | Meals · 2025-07-07 | Nuzyra | $22 |
| Reprise Biomedical | Meals · 2025-06-11 | Miro3d | $21 |
| Smith+Nephew | Meals · 2025-06-10 | Stravix | $3 |
| Integra LifeSciences | Meals · 2025-05-15 | Tcc-Ez | $22 |
| Smith+Nephew | Meals · 2025-05-14 | Grafix | $148 |
| Stryker | Meals · 2025-05-13 | Ortholoc 2 Lapifuse | $28 |
| Alafair Biosciences | Meals · 2025-05-06 | Versawrap | $28 |
| ConvaTec | Meals · 2025-05-01 | Aquacel Foam | $14 |
| Amgen | Meals · 2025-04-15 | Krystexxa | $30 |
| Amgen | Meals · 2025-04-08 | Krystexxa | $125 |
| Amgen | Meals · 2025-04-04 | Krystexxa | $9 |
| Smith+Nephew | Meals · 2025-04-04 | Collagenase Santyl | $23 |
| Vertex Pharmaceuticals | Meals · 2025-03-25 | Journavx | $24 |
| Smith+Nephew | Meals · 2025-03-18 | Stravix | $46 |
| Avita Medical Americas | Meals · 2025-03-11 | Recell | $135 |
| Stryker | Meals · 2025-02-25 | Fuseforce | $11 |
| Stryker | Meals · 2025-02-12 | Actishield | $16 |
| Paratek Pharmaceuticals | Meals · 2025-01-21 | Nuzyra | $14 |
| DePuy Synthes Sales | Meals · 2025-01-14 | Motoband | $93 |
| Evolution Surgical | Meals · 2025-01-08 | None | $46 |
| Curonix | Meals · 2025-01-07 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $111 |
| DePuy Synthes Sales | Meals · 2025-01-03 | Motoband | $50 |
See earlier years (2024, 2023, 2022)
2024: $1,908
| Stryker | Augment Injectable | $376 | 2 payments
|
| Smith+Nephew | Grafix | $241 | 8 payments
|
| Exactech | Vantage | $213 | 1 payment
|
| Kerecis | Kerecis Omega3 Surgiclose | $196 | 2 payments
|
| Treace Medical Concepts | Lapiplasty System | $190 | 1 payment
|
| Paragon 28 | Bun-Yo-Matic | $161 | 2 payments
|
| Averitas Pharma | Qutenza | $157 | 2 payments
|
| Alafair Biosciences | Versawrap | $149 | 1 payment
|
| Biotissue Holdings | None | $84 | 3 payments
|
| DePuy Synthes Sales | VA-Lcp | $44 | 1 payment
|
| Amgen | Krystexxa | $43 | 2 payments
|
| Avita Medical Americas | Recell | $20 | 1 payment
|
| Vertex Pharmaceuticals | None | $17 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $17 | 1 payment
|
2023: $288
| Stryker | Ortholoc 2 Lapifuse | $182 | 2 payments
|
| Averitas Pharma | Qutenza | $46 | 2 payments
|
| Paragon 28 | Paratrooper | $30 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $16 | 1 payment
|
| Evolution Surgical | None | $14 | 1 payment
|
2022: $1,343
| Evolution Surgical | None | $1,200 | 1 payment
|
| Smith+Nephew | Stravix | $143 | 2 payments
|
Checkups this office reported
2 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
| Patients can see their records onlinePatients who were given electronic access to their health information | 93%That's most of the people this applied to. | 240 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 91%That's most of the people this applied to. | 106 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1699487215
- Licence
- CA EL6985
- Trained
- Barry University School of Podiatric Medicine, 2020
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 3801 Miranda Ave, Palo Alto, CA, 94304
- NPI first listed
- 2022-12-14
- NPI last updated
- 2023-07-02
- NPI record certified
- 2023-07-02
This is when the NPI record was last certified, not a medical board exam.